Lack of prognostic value of EGFR mutations in primary resected non-small cell lung cancer.

Purpose To investigate the prognostic value of epidermal growth factor receptor (EGFR) mutations in a series of Taiwanese patients with primary resected lung adenocarcinomas never treated with epidermal growth factor receptor tyrosine kinase (TK) inhibitor.